Eye drop for cataracts to be evaluated in pilot study

ZOC2017217, an eye drop aimed at slowing or reversing the development of cataracts, is undergoing a pilot study ahead of a potential phase 3 trial, according to a press release from Lexitas Pharma Services and Ocusun. “Today, cataract surgery is the only established treatment for cataracts,” Nevin El-Nimri, OD, senior director of clinical and medical affairs at Lexitas Pharma Services, told

Raccontata damorningstar.comhealio.com